Larvol Delta - Comanche-Biopharma-Awarded-Innovation-Passport-Designation-by-the-UK-Innovative-Licensing-and-Access-Pathway-ILAP-Steering-Group-for-CBP4888-an-Investigational-siRNA-Drug-Candidate-for-the-Treatment-of-sFlt1mediated-Preterm-Preeclampsia

CBP-4888 - Comanche Biopharma

https://www.globenewswire.com/news-release/2025/01/30/3017772/0/en/Comanche-Biopharma-Awarded-Innovation-Passport-Designation-by-the-U-K-Innovative-Licensing-and-Access-Pathway-ILAP-Steering-Group-for-CBP-4888-an-Investigational-siRNA-Drug-Candida.html

Jan 30, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next